|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.40 USD | +0.13% |
|
+0.13% | +55.53% |
| Jan. 08 | BTIG Downgrades Inari Medical to Neutral From Buy | MT |
| Jan. 07 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
| Capitalization | 4.64B 4.51B 4.24B 3.79B 6.66B 401B 7.46B 51.79B 19.21B 165B 17.42B 17.05B 727B | P/E ratio 2024 * |
-66.9x | P/E ratio 2025 * | 1,219x |
|---|---|---|---|---|---|
| Enterprise value | 4.57B 4.44B 4.18B 3.74B 6.56B 395B 7.35B 51.02B 18.92B 162B 17.16B 16.8B 716B | EV / Sales 2024 * |
7.58x | EV / Sales 2025 * | 6.36x |
| Free-Float |
91.26% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Inari Medical, Inc.
More recommendations
More press releases
More news
| 1 day | +0.13% | ||
| 1 week | -0.06% | ||
| Current month | +55.53% | ||
| 1 month | +42.83% | ||
| 3 months | +88.15% | ||
| 6 months | +45.93% | ||
| Current year | +55.53% |
1 week
79.16
79.50
1 month
47.2579.69
Current year
47.2579.69
1 year
36.7379.69
3 years
36.73100.00
5 years
36.73127.42
10 years
36.73127.42
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Hykes
CEO | Chief Executive Officer | 52 | 2022-12-30 |
Kevin Strange
DFI | Director of Finance/CFO | - | 2024-09-30 |
Norman Nie
CTO | Chief Tech/Sci/R&D Officer | - | 2019-03-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Root
BRD | Director/Board Member | 65 | 2011-08-31 |
William Hoffman
BRD | Director/Board Member | 57 | 2015-02-08 |
Cynthia Lucchese
BRD | Director/Board Member | 64 | 2019-10-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.15% | 1,676 M€ | +1.81% | - | |
| 0.08% | 0 M€ | -.--% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.13% | -0.06% | +37.25% | +1.94% | 4.64B | ||
| -0.01% | +0.01% | +54.88% | +100.50% | 12.57B | ||
| +3.51% | +3.78% | +1.31% | +10.18% | 9.71B | ||
| +3.60% | +3.94% | +45.43% | -26.18% | 8.89B | ||
| -0.17% | +3.17% | +2.77% | -0.65% | 4.82B | ||
| -1.76% | -0.78% | +35.40% | +115.57% | 4.66B | ||
| +0.62% | +1.90% | -17.54% | -43.55% | 4.54B | ||
| -0.32% | -2.28% | -19.44% | +13.33% | 4.31B | ||
| +0.46% | -9.17% | +96.79% | -61.88% | 2.84B | ||
| -1.23% | +0.17% | -35.50% | -64.42% | 1.32B | ||
| Average | +0.35% | -0.05% | +20.13% | +4.48% | 5.83B | |
| Weighted average by Cap. | +0.91% | +0.19% | +26.10% | +21.82% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 603M 586M 551M 493M 865M 52.11B 969M 6.73B 2.49B 21.38B 2.26B 2.22B 94.46B | 712M 692M 650M 581M 1.02B 61.49B 1.14B 7.94B 2.94B 25.23B 2.67B 2.61B 111B |
| Net income | -69.26M -67.32M -63.24M -56.6M -99.32M -5.98B -111M -773M -287M -2.46B -260M -254M -10.85B | 3.92M 3.81M 3.58M 3.2M 5.62M 338M 6.3M 43.69M 16.2M 139M 14.7M 14.39M 613M |
| Net Debt | -69.15M -67.21M -63.14M -56.51M -99.16M -5.98B -111M -771M -286M -2.45B -259M -254M -10.83B | -117M -114M -107M -95.45M -168M -10.09B -188M -1.3B -483M -4.14B -438M -429M -18.3B |
More financial data
* Estimated data
Employees
1,300
Calendar
2025-03-03
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-15 | 79.40 $ | +0.13% | 3,707,279 |
| 25-01-14 | 79.30 $ | -0.05% | 3,367,523 |
| 25-01-13 | 79.34 $ | +0.06% | 6,273,078 |
| 25-01-10 | 79.29 $ | -0.01% | 11,611,130 |
| 25-01-08 | 79.30 $ | -0.19% | 11,583,248 |
Delayed Quote Nasdaq, January 15, 2025 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
79.30USD
Average target price
74.12USD
Spread / Average Target
-6.53%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NARI Stock